Skip to main content
Normal View

Hepatitis C Incidence

Dáil Éireann Debate, Tuesday - 16 October 2012

Tuesday, 16 October 2012

Questions (709)

Caoimhghín Ó Caoláin

Question:

709. Deputy Caoimhghín Ó Caoláin asked the Minister for Health if he will use his powers under the Hepatitis C Compensation Tribunal Act 1997 to make available the measures provided for the majority who have tested positive to the small number of women who received blood products from contaminated batches of anti-d in the 1977 to 1979 and 1991 to 1994 periods but who are testing negative while experiencing severe health problems consistent with testing positive; and if he will make a statement on the matter. [44933/12]

View answer

Written answers

The Health Amendment Act (HAA) Card is given to men, women and children who contracted Hepatitis C from the administration within the State of blood or blood products.

Under the Health (Amendment) Act,1996 the entitlement of an individual to a HAA Card and to related services is decided by the Health Service Executive (HSE). The HSE is bound by the definition of eligibility in the Hepatitis C Compensation Tribunal (Amendment) Act 2006, which requires a positive diagnostic test for applications received by the Tribunal after the specified date of 20 June, 2006.

A great deal of consideration has been given to the issue of recipients of Anti-D who have neither tested positive for Hepatitis C, nor had a positive Tribunal decision in their favour. A number of women who have tested negative for Hepatitis C have experienced a variety of symptoms. However, there is no scientific proof that the symptoms are specific evidence of Hepatitis C infection. Indeed some symptoms of Hepatitis C, such as fatigue, fibromyalgia and depression, are common conditions that occur in the general population.

It is estimated that up to 16,000 women in Ireland were exposed to potentially infectious batches of Anti-D and approximately 1,000 of these women were infected with Hepatitis C. Extending eligibility for HAA cards to those who have tested negative for Hepatitis C would have significant implications for the scheme overall.

I am sympathetic to the women in question, but taking account of international practice and the rationale which led to the passing of the 2006 Act, I am satisfied that the present arrangements are reasonable in the circumstances. I will of course review any new information which becomes available in relation to this matter.

Top
Share